Vinay Prasad

AstraZeneca FluMist Home ad
Marketing

AstraZeneca TV spot for at-home FluMist lands in FDA crosshairs

On the same day the Trump administration laid out its plan to rein in DTC drug advertising, the FDA sent out its first untitled letter in months.
Andrea Park Sep 16, 2025 11:07am
FDA

FDA to take harder look at coadministration of certain vaccines

Sep 4, 2025 10:40am
FDA

Vinay Prasad is back at the FDA after last month's surprise ouster

Aug 9, 2025 12:22pm
Graphic of a fork in the road with arrows pointing in either direction

Prasad exit signals more permissive FDA for cell and gene field

Jul 31, 2025 9:10am
FDA

Vinay Prasad departs FDA amid controversy over gene therapy

Jul 30, 2025 9:33am
FDA

FDA investigates 2 deaths after Sarepta Duchenne gene therapy

Jun 25, 2025 10:26am